Literature DB >> 23973631

Validated LC-MS/MS method for the determination of 3-hydroxflavone and its glucuronide in blood and bioequivalent buffers: application to pharmacokinetic, absorption, and metabolism studies.

Beibei Xu1, Guanyi Yang, Shufan Ge, Taijun Yin, Ming Hu, Song Gao.   

Abstract

The purpose of this study is to develop an UPLC-MS/MS method to quantify 3-hydroxyflavone (3-HF) and its metabolite, 3-hydroxyflavone-glucuronide (3-HFG) from biological samples. A Waters BEH C8 column was used with acetonitrile/0.1% formic acid in water as mobile phases. The mass analysis was performed in an API 5500 Qtrap mass spectrometer via multiple reaction monitoring (MRM) with positive scan mood. The one-step protein precipitation by acetonitrile was used to extract the analytes from blood. The results showed that the linear response range was 0.61-2500.00 nM for 3-HF and 0.31-2500.00 nM for 3-HFG. The intra-day variance is less than 16.5% and accuracy is in 77.7-90.6% for 3-HF and variance less than 15.9%, accuracy in 85.1-114.7% for 3-HFG. The inter-day variance is less than 20.2%, accuracy is in 110.6-114.2% for 3-HF and variance less than 15.6%, accuracy in 83.0-89.4% for 3-HFG. The analysis was done within 4.0 min. Only 10 μl of blood is needed due to the high sensitivity of this method. The validated method was successfully used to pharmacokinetic study in A/J mouse, transport study in the Caco-2 cell culture model, and glucuronidation study using mice liver and intestine microsomes. The applications revealed that this method can be used for 3-HF and 3-HFG analysis in blood as well as in bioequivalent buffers such HBSS and KPI.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3-HF; 3-HFG; 3-Hydroxyflavone; 3-hydroxyflavone; 3-hydroxyflavone-glucuronide; AUC; Absorption; CE; CXP; DP; HBSS; Hank's balanced salt solution; I.S.; KPI; LLOQ; MPA; MPB; Metabolism; Pharmacokinetics; QC; UDPGA; UPLC; UPLC–MS/MS; area under the curve; collision cell exit potential; collision energy; declustering potential; internal standard; lower limit of quantification; mobile phase A; mobile phase B; potassium phosphate buffer; quality control; ultra-performance liquid chromatography; uridine-5′-diphosphate-β,d-glucuronic acid ester

Mesh:

Substances:

Year:  2013        PMID: 23973631      PMCID: PMC4385390          DOI: 10.1016/j.jpba.2013.07.030

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  18 in total

1.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

Review 2.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

3.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

4.  The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes.

Authors:  Eung-Ryoung Lee; Jung-Hyun Kim; Yong-Jin Kang; Ssang-Goo Cho
Journal:  Biol Pharm Bull       Date:  2007-01       Impact factor: 2.233

5.  Excited state proton transfer and solvent relaxation of a 3-hydroxyflavone probe in lipid bilayers.

Authors:  Ranjan Das; Andrey S Klymchenko; Guy Duportail; Yves Mély
Journal:  J Phys Chem B       Date:  2008-08-27       Impact factor: 2.991

6.  Validated LC-MS/MS method for the determination of maackiain and its sulfate and glucuronide in blood: application to pharmacokinetic and disposition studies.

Authors:  Song Gao; Zhen Yang; Taijun Yin; Ming You; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2011-01-22       Impact factor: 3.935

7.  Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells.

Authors:  Eung-Ryoung Lee; Yong-Jin Kang; Hyun-Jeong Kim; Hye-Yeon Choi; Geun-Ho Kang; Jung-Hyun Kim; Bong-Woo Kim; Hyo-Soon Jeong; Yong-Sun Park; Ssang-Goo Cho
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

8.  Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition.

Authors:  Bong-Woo Kim; Eung-Ryoung Lee; Hye-Min Min; Hyo-Soon Jeong; Jae-Yeon Ahn; Jung-Hyun Kim; Hye-Yeon Choi; Hana Choi; Eun Young Kim; Se Pill Park; Ssang-Goo Cho
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

9.  Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method.

Authors:  Zhen Yang; Song Gao; Taijun Yin; Kaustubh H Kulkarni; Yang Teng; Ming You; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2009-11-26       Impact factor: 3.935

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.